Conclusion

Studies on COVID-19 in children are vital to better understand their unique epidemiological trends, clinical course, laboratory and radiological findings, and prognosis and outcomes. Significant differences exist in all these factors compared to adults. To date, data in children is heavily skewed toward cases from China, and more data is needed from a wider geographic area. This will better prepare us as the cases rise and the dynamics of the pandemic continue to evolve. Emerging information on the proportion of asymptomatic cases and its eventual effect on spread of disease will benefit healthcare providers and public health officers to design appropriate policies, especially with the impending re-opening of schools.